Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

118P - Correlation between PD-L1 expression/TMB and immune cell infiltration: A pan-cancer study

Date

17 Sep 2020

Session

E-Poster Display

Topics

Targeted Therapy

Tumour Site

Presenters

Jianping Xiong

Citation

Annals of Oncology (2020) 31 (suppl_4): S274-S302. 10.1016/annonc/annonc266

Authors

J. Xiong1, X. Xiang1, J. Li1, S. Huang1, Y. Chen2

Author affiliations

  • 1 Medical Oncology, The first affiliated hospital of nanchang university, 330006 - Jiangxi/CN
  • 2 The Research And Development Center Of Precision Medicine, 3D Medicines Inc., 201114 - shanghai/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 118P

Background

Clinical studies have shown that only 20-30% patients with respond to immune checkpoint inhibitors. Defining biomarkers that predict therapeutic effects is a crucial mandate. Currently, the effective biomarkers affecting immune checkpoint inhibitors include PD-L1, MSI, dMMR, Tumor Mutational Burden (TMB), Neoantigen, etc. The expression level of PD-L1 is still the most important indicator, and more and more attention has been paid to TMB as a biomarker in clinic use. However, the relationship between pd-l1 expression /TMB and immune cell infiltration (ICI) has not been fully studied.

Methods

FFPE tissues were collected from 272 Chinese patients with malignant tumors. Multiple immunohistochemistry (mIHC) was performed on the tumor tissue, including PD-L1, CD8, CD56, CD68, HLA-DR. Next generation sequencing (NGS) was performed among 58 patients to further measure TMB.

Results

Among 262 patients, 36% (97/272) are gastrointestinal tumors; 35% (94/272) are hepatobiliary and pancreatic tumors; 22% (61/272) are non-small cell lung cancer; 8% (20/272) are other tumor type. Our result show that infiltration of CD8 T cell (CD8+) and macrophage M1 cell (CD68+ HLA-DR+) are positive correlated with PD-L1 expression (p=0.0143,p=0.0412,respectively;17%,46/273,PD-L1 positive; 83%,226/272, PD-L1 negative). Infiltration of NK cell (CD56 Dim and bright) and macrophage M2 cell (CD68+ HLA-DR-) have none relevant with PD-L1 expression. We further explored correlation between TMB and ICI by NGS sequencing and mIHC. Infiltration of CD8 T cell and NK cell (CD56 bright) are positive correlated with TMB-H, as compared to TMB-L tumors (p=0.0279, p=0.0407, respectively; Top25%, 15/58.TMB-H; Last 75%, 43/58, TMB-L).

Conclusions

PD-L1 positive tumors may have higher infiltration of CD8 T cell and macrophage M1 cell, while TMB-H tumors may have higher infiltration of CD8 T cell and CD56 bright NK cell.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The first affiliated hospital of Nanchang university.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.